Taxpayers and patients cannot afford to pay a high price for a treatment not known to be effective.
Alzheimer’s disease
Controversial new Alzheimer’s drug gives patients in Maine hope
The treatment developed by Biogen could slow its progression, but health professionals and researchers are divided on whether the FDA was right to approve it.
Another View: Alzheimer’s drug furor highlights U.S. health system’s failures
Is aducanumab a breakthrough or a boondoggle? U.S. health policy offers reason to worry.
FDA approves new drug for Alzheimer’s that experts doubt will work
The decision is sure to spark disagreements among doctors, medical researchers and patient groups, and have far-reaching implications for the standards used to evaluate experimental therapies.
Maine Voices: A different way to say ‘I love you’
As Tony Bennett has shown us, Alzheimer’s disease doesn’t dim the gift of or the joy in music.
Midcoast respite care center to open new location after closing amid pandemic
The nonprofit provides activities for people with dementia and Alzheimer’s disease and resources such as support groups, community education and one-on-one counseling for caretakers.
Maine CDC reports 71 new coronavirus cases as outbreak hits Cape Elizabeth memory care home
The additional cases and 2 deaths come at a time when the Mills administration is relaxing restrictions on businesses to begin reviving Maine’s economy.
Drugs fail to slow effects of inherited Alzheimer’s disease
Two experimental drugs have failed to prevent or slow mental decline in a study of people who are virtually destined to develop the disease because of rare gene flaws.
Commentary: There is nothing loving about killing disabled people
When a partner kills his disabled loved one, we see it as an act of kindness or mercy. It isn’t.
Our View: Maine study part of effort to solve Alzheimer’s puzzle
In the oldest state in the nation, finding a cure has never been more important.